Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (NYSE: IFF) is a global leader in sensory experiences and specialty ingredients, serving industries from food technology to pharmaceutical solutions. This dedicated news hub provides investors and industry professionals with essential updates on IFF developments, including earnings reports, strategic partnerships, and scientific breakthroughs.
Key resources include: Quarterly financial results, innovation announcements in flavors/fragrances, bioscience advancements, and sustainability initiatives. Our curated collection ensures access to verified press releases and market analyses that impact IFF's position in the $120B+ specialty chemicals sector.
Bookmark this page for real-time updates on IFF's product launches, regulatory milestones, and leadership changes. Combine technical insights with strategic context to make informed decisions about this NYSE-listed innovator.
IFF (NYSE: IFF) has announced its quarterly dividend for Q2 2025. The Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of common stock. The dividend will be payable on July 11, 2025 to shareholders of record as of June 20, 2025.
IFF is a global leader in flavors, fragrances, food ingredients, health and biosciences, focusing on delivering sustainable innovations for everyday products.
IFF has successfully completed the divestiture of its Pharma Solutions business unit to Roquette. CEO Erik Fyrwald announced that this strategic move has helped the company achieve its targeted net debt to credit-adjusted EBITDA ratio of below 3.0x.
The divestiture marks a significant milestone for IFF, enabling the company to focus on its core strategy and maximize shareholder value by capitalizing on growth opportunities within its key businesses. The company expressed gratitude to the Pharma Solutions team for their dedication to customer service.
IFF remains a global leader in flavors, fragrances, food ingredients, health and biosciences, delivering sustainable innovations for everyday products that enhance wellness and the human experience.
IFF Pharma Solutions will showcase its sustainable pharmaceutical innovations at Excipient World 2025, taking place May 13-14 at the Gaylord National Resort and Convention Center in Maryland. The company will present its portfolio at booth 205, featuring sustainable solutions, controlled-release formulations, and nitrosamine risk mitigation products.
Key highlights include:
- Presentation of METHOCEL™, ETHOCEL™, and POLYOX™ product lines
- Introduction of Low Nitrite METHOCEL™ and Avicel® PH LN for reducing nitrosamine risks
- Sustainability expert Dr. Anne Adden's presentation on "Sustainable by Design: The Future of Excipients" on May 13
The event will showcase IFF's 75+ years of industry expertise in polymer innovations. Dr. Adden, global strategic marketing director for sustainability and dietary supplements, emphasizes the company's commitment to creating sustainable healthcare solutions that address both current needs and future challenges.
IFF (NYSE: IFF) has announced a significant expansion of its pet portfolio, introducing advanced biotechnology solutions for companion animal care. The company has launched new products including Microsource™ CA for cat litter management and Betafin® Pet for pet hydration and gut health.
The expansion is supported by specialized R&D centers including the Pet Translational Research Lab (Wilmington, DE), Pet Enzymes Lab (Brabrand, Denmark), and Pet Applications Lab (New Century, KS). The new portfolio features enzyme-driven palatability solutions, sustainable ingredients, and functional health technologies.
Microsource™ CA reduces fecal ammonia odors by four times within 7 days, while Betafin® Pet offers natural betaine for both dogs and cats. The portfolio also includes enzymes, probiotics, plant protein, food protection solutions, natural colors, and proprietary flavor technology.
IFF (NYSE: IFF) Pharma Solutions has announced its participation at Vitafoods™ Europe 2025, showcasing its plant-based dietary supplement ingredients portfolio. The event will take place May 20-22 at the Fira Barcelona Gran Via, booth 4F25.
The company will present several innovative brands including SeaGel®, VERDIGEL™ SC, GRINDSTED® Pectin Premium, Ac-Di-Sol®, Avicel®, Accelerate®, and METHOCEL™. These products offer solutions ranging from vegan softgels and plant-based gummies to tablet binders and disintegrants.
The showcase highlights IFF's commitment to advancing the dietary supplement industry through high-performance, plant-based ingredients and reliable technologies for immediate and controlled release applications.
IFF (NYSE: IFF) has inaugurated its Scent Dubai Creative Center, a 2,000-square-meter facility at the Dubai Science Park Laboratory Complex. The center aims to strengthen IFF's presence in the Middle East's perfumery market, which is projected to reach $7 billion by 2034.
The state-of-the-art facility features a perfumery art studio for customer co-creation, a traditional Middle Eastern majlis, and an academy for perfumery training. It is equipped with advanced technology including a semi-industrial production robot and evaluation booths for various scent categories.
The center serves as an extension of IFF's Atelier du Perfumeur in Grasse and Shanghai Perfumery Art Studio, focusing on creating innovative fragrance solutions for the region's unique consumer demands in fine fragrances, home, fabric, and beauty care products.
IFF (NYSE:IFF) has announced it will release its first quarter 2025 earnings results after market close on Tuesday, May 6, 2025. The management team will host a live webcast on Wednesday, May 7, 2025, at 9:00 a.m. ET to discuss results and outlook with investors.
Investors can access the webcast and accompanying slide presentation through the company's website at ir.iff.com. A recorded version will be available for those unable to attend the live event.
IFF (NYSE: IFF) announced the consolidation of its Mexico operations at a new site in Mexico City's Tecnoparque business complex. The relocation will start with the Global Business Services Center and is expected to complete by 2026. The new facility will accommodate up to 650 employees across Health & Biosciences, Scent, Taste, and Food Ingredients divisions.
The strategic move includes laboratories for product creation, testing, R&D, and business services. The Tecnoparque complex features 50,000 square meters of green space, solar power generation, and advanced water management systems. IFF's existing Tlalnepantla facilities will continue operating as a strategic production site for Scent and Taste business units.
IFF (NYSE: IFF) has unveiled its new Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. The 30,000 square foot facility features state-of-the-art capabilities in botanical research, processing, analytics, and product creation for scent and taste applications.
The center includes advanced technologies like a 360-degree digital immersion room and focuses on applications in food and beverage, fine fragrance, body care, and fabric & home care. Supporting approximately 40 jobs, the facility emphasizes sustainability with LEED silver certification and a solar array system meeting its entire power demand.
The center demonstrates IFF's commitment to innovation and external partnerships, offering customers rapid product development capabilities, innovative citrus applications, and advanced product testing. Located on Florida Polytechnic University's campus, the facility provides direct access to industry experts and academia while featuring on-site prototyping capabilities for customized solutions.
FAQ
What is the current stock price of International Flavors&Fragranc (IFF)?
What is the market cap of International Flavors&Fragranc (IFF)?
